Cover Image
市場調查報告書

分子生物感應器的全球市場:成長,趨勢及預測(2017年∼2022年)

Global Molecular Biosensors Market - Growth, Trends & Forecast (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 391373
出版日期 內容資訊 英文 205 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
分子生物感應器的全球市場:成長,趨勢及預測(2017年∼2022年) Global Molecular Biosensors Market - Growth, Trends & Forecast (2017 - 2022)
出版日期: 2017年01月24日 內容資訊: 英文 205 Pages
簡介

生物感應器,是活用生物學的特異性識別目標分子的分析工具。使用生物感應器技術,檢查循環系統疾病和癌症,糖尿病,感染疾病等的人類的各種健康狀態。遺傳學,藥物療法,含生物資訊科學等的科學性專門領域的進步,促進了新的生物標記的發現。現在市場上,為了癌症生物標記的早期發現可利用各種診斷檢驗(非侵襲/微創)。這是較食品、飲料和環境安全性,安全保障、防衛以及其他的分子生物感應器用途相關等領域為對象的市場還要巨大的市場。

本報告提供全球分子生物感應器市場調查,整體市場趨勢,產品、各地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 調查的成果
  • 市場定義
  • 數量單位
  • 基本貨幣
  • 檢討與預測期間
  • 一般調查的前提條件

第2章 調查方法

  • 簡介
  • 分析方法論
  • 計量預測模式
  • 調查的前提條件

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要與產業趨勢

  • 目前市場方案
  • 分子生物感應器的應用
  • 技術概要
  • 最新趨勢
  • 產業價值鏈分析
  • 產品生命週期分析
  • 產品基準
  • 投資分析
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品及服務的威脅
    • 產業內的競爭

第6章 成長要素,阻礙因素,機會,課題分析(DROC)

  • 市場成長要素
    • 慢性及文明病的盛行率的增加
    • 醫護檢查站需求的增加
    • 各種產業上生物感應器的利用擴大
  • 市場阻礙因素
    • 生物感應器的嚴格法規必要條件
    • 醫療制度的償付政策的問題
  • 主要課題
  • 市場上目前機會

第7章 市場區隔

  • 各應用領域
    • 醫療診斷
    • 製藥、生物科技
    • 食品和飲料
    • 環境安全性
    • 防衛、安全保障
    • 其他
  • 各技術
    • 電化學生物感應器
    • 光學生物感應器
    • 熱生物感應器
    • 壓電生物感應器
  • 各類型
    • 生物學的訊號傳達
    • 傳達要素
    • 認識要素
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區(MEA)
    • 中南美

第8章 競爭情形

  • M&A分析
  • 專利分析
  • 競爭對手

第9章 企業簡介

  • Siemens Healthcare
  • LifeSensors, Inc.
  • Nova biomedical Corporation
  • Abbott Laboratories, Inc.
  • Johnson and Johnson
  • Medtronic, Inc.
  • F. Hoffmann La Roche
  • Bayer AG

第10章 投資機會的分析師預期

第11章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Description

The Global Market for Molecular Biosensors is estimated to reach maximum of $XX by 2020 at an increasing CAGR of XX% from the current status of $XX in 2014.

Biosensors are analytical tools using biological specificity to sense the target molecule. The biosensor technology is used for the detection of various human health-related conditions such as cardiovascular disease, cancer, diabetes and infectious diseases. Advances in scientific disciplines that include genetics, medicine, bioinformatics, etc., fueled the discovery of new biomarkers. Many diagnostic tests (noninvasive/minimally invasive) for the early detection of cancer biomarkers are available on the market. This is a huge market compared to the markets covered for Food and Beverages, Environment safety, Defense and security and other areas pertaining to molecular biosensors applications.

Molecular biosensor market benefits investors, clinical laboratories, hospitals, pharmaceutical companies, biotechnology companies, chemical sensor companies, contract research organizations, environment safety agencies and health regulatory authorities.

The market for molecular biosensors is segmented on basis of Application (Medical diagnostics, pharma & biotech, Food and Beverages, Environment safety, Defense and security and others), Technology (Electrochemical Biosensors, Optical Biosensors, Thermal Biosensors and Peizoelectric Biosensors), Type (Biological Signaling, Transduction element and Recognition element) and Geographical Regions.

Geographically, North America has the largest share in global molecular biosensors market, followed by Europe. While Asia-Pacific also has emerged as the fastest growing region in this market.

Some of the major competitors include Siemens Healthcare, LifeSensors, Inc., Nova biomedical Corporation, Abbott Laboratories, Inc., Johnson and Johnson, Medtronic, Inc., F. Hoffmann La Roche, and Bayer AG

Drivers

Increasing prevalence of chronic and lifestyle induced diseases, Increasing diabetic population, increasing demand for Point of Care Testing (POCT), rise in geriatric population and increasing application of biosensors in various industries are major factors driving the growth of this market.

Restraints

Strict regulatory requirements for biosensors and Reimbursement policies issues in healthcare systems are major constraints for the growth of biosensors market.

What the report offers?

1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2) Market analysis for the Global Molecular Biosensors Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.

3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

5)Identification and analysis of the Macro and Micro factors that affect the Global Molecular Biosensors Market in Healthcare Industry on both global and regional scale.

6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. Introduction

  • 1.1 Study Deliverables
  • 1.2 Market Definition
  • 1.3 Sizing Units
  • 1.4 Base Currency
  • 1.5 Review and Forecast Period Years
  • 1.6 General Study Assumptions

2. Research Methodology

  • 2.1 Introduction
  • 2.2 Analysis Methodology
  • 2.3 Econometric Forecast Model
  • 2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

  • 5.1 Current Market Scenario
  • 5.2 Applications of Molecular Biosensors
  • 5.3 Technology Overview
  • 5.4 New Developments
  • 5.5 Industry Value-Chain Analysis
  • 5.6 Product Life-Cycle Analysis
  • 5.7 Product Benchmarking
  • 5.8 Investment Analysis
  • 5.8 Porter's Five Forces
    • 5.8.1 Bargaining Power of Suppliers
    • 5.8.2 Bargaining Power of Consumers
    • 5.8.3 Threat of New Entrants
    • 5.8.4 Threat of Substitute Products and Services
    • 5.8.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Increasing prevalence of chronic and lifestyle induced diseases
    • 6.1.2 Increasing demand for Point of Care Testing
    • 6.1.3 Increasing application of biosensors in various industries
  • 6.2 Market Restraints
    • 6.2.1 Strict regulatory requirements for biosensors
    • 6.2.2 Reimbursement policies issues in healthcare systems
  • 6.3 Key Challenges
  • 6.4 Current Opportunities in the Market

7. Market Segmentation

  • 7.1 By Application
    • 7.1.1 Medical diagnostics
    • 7.1.2 Pharma & biotech
    • 7.1.3 Food and Beverages
    • 7.1.4 Environment safety
    • 7.1.5 Defense and security
    • 7.1.6 Others
  • 7.2 By Technology
    • 7.2.1 Electrochemical Biosensors
    • 7.2.2 Optical Biosensors
    • 7.2.3 Thermal Biosensors
    • 7.2.4 Peizoelectric Biosensors
  • 7.3 By Type
    • 7.3.1 Biological Signaling
    • 7.3.2 Transduction element
    • 7.3.3 Recognition element
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.0 Introduction
      • 7.4.1.1 US
      • 7.4.1.2 Canada
      • 7.4.1.3 Rest of North America
    • 7.4.2 Europe
      • 7.4.2.0 Introduction
      • 7.4.2.1 France
      • 7.4.2.2 UK
      • 7.4.2.3 Germany
      • 7.4.2.4 Russia
      • 7.4.2.5 Italy
      • 7.4.2.6 Spain
      • 7.4.2.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.0 Introduction
      • 7.4.3.1 India
      • 7.4.3.2 China
      • 7.4.3.3 Japan
      • 7.4.3.4 Australia
      • 7.4.3.5 Soth Korea
      • 7.4.3.6 Rest of Asia Pacific
    • 7.4.4 Middle-East and Africa (MEA)
      • 7.4.4.1 Introduction
      • 7.4.4.2 UAE
      • 7.4.4.3 Saudi Arabia
      • 7.4.4.4 Israel
      • 7.4.4.5 Rest of the MEA
    • 7.4.5 Latin America
      • 7.4.5.1 Introduction
      • 7.4.5.2 Brazil
      • 7.4.5.1 Argentina
      • 7.4.5.4 Mexico
      • 7.4.5.5 Rest of Latin America

8. Competitive Landscape

  • 8.1 Merger and Acquisition Analysis
  • 8.2 Patent Analysis
  • 8.3 The Challengers

9. Company Profiles

  • 9.1 Siemens Healthcare
  • 9.2 LifeSensors, Inc.
  • 9.3 Nova biomedical Corporation
  • 9.4 Abbott Laboratories, Inc.
  • 9.5 Johnson and Johnson
  • 9.6 Medtronic, Inc.
  • 9.7 F. Hoffmann La Roche
  • 9.8 Bayer AG

10. Analyst Outlook for Investment Opportunities

11. Future Outlook of the Market

Back to Top